Next |
home / stock / enta / enta message board
Subject | By | Source | When |
---|---|---|---|
Investing in biotech can be risky so you | vinmantoo | investorshub | 05/09/2023 4:25:54 PM |
Vin, its good. Stay optimistic. | Jake2234 | investorshub | 05/09/2023 12:43:10 PM |
The after hours trades means lots of pain | vinmantoo | investorshub | 05/09/2023 5:15:17 AM |
Yeah the market just tanked this thing and | Jake2234 | investorshub | 05/09/2023 1:10:04 AM |
My agenda is to speak the truth. | vinmantoo | investorshub | 05/09/2023 12:33:11 AM |
Now you are coming around! Great job. | Jake2234 | investorshub | 05/08/2023 11:31:56 PM |
Well, you deny that your bullish thesis was | vinmantoo | investorshub | 05/08/2023 11:04:10 PM |
My agenda is to speak the truth. Anyone | Jake2234 | investorshub | 05/08/2023 11:01:05 PM |
Well, you deny that your bullish thesis was | Jake2234 | investorshub | 05/08/2023 9:49:31 PM |
EDP-235 phase-2 slide set: | DewDiligence | investorshub | 05/08/2023 9:37:07 PM |
Now you deny. | vinmantoo | investorshub | 05/08/2023 9:28:45 PM |
Now you deny. Wow. Buying more shares for | Jake2234 | investorshub | 05/08/2023 9:22:38 PM |
Now trading at $24. I suppose your opinion | vinmantoo | investorshub | 05/08/2023 9:21:07 PM |
$ENTAIt looks like the 400mg (higher) dose will | DewDiligence | investorshub | 05/08/2023 9:03:38 PM |
Now trading at $24. I suppose your opinion | Jake2234 | investorshub | 05/08/2023 8:43:57 PM |
Key secondary endpoints evaluating virologic effect were not | Jake2234 | investorshub | 05/08/2023 8:32:12 PM |
$ENTA FY2Q23* financials3/31/23 pro forma cash=$454M : | DewDiligence | investorshub | 05/08/2023 8:20:30 PM |
$ENTA reports phase-2 data for EDP-235: | DewDiligence | investorshub | 05/08/2023 8:08:52 PM |
$ENTA what do you make of this data? | vinmantoo | investorshub | 05/06/2023 11:32:12 AM |
$ENTA where is the squeeze? | willyw | investorshub | 05/03/2023 4:22:06 PM |
News, Short Squeeze, Breakout and More Instantly...
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
NASDAQ Market:
Enanta Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Nuwellis Inc. (NUWE) rose 60.3% to $0.2741 on volume of 66,284,094 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 21.1% to $0.05 on volume of 64,247,106 shares Clearmind Medicine Inc. (CMND) rose 37.6% to $1.61 on volume ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strate...
Anticipates Reporting Topline Data from EDP-323 Respiratory Syncytial Virus (RSV) Challenge Study in Q3 2024 and Phase 2 Study of Zelicapavir in Pediatric RSV Patients in 2H 2024 Selection of Chronic Spontaneous Urticaria (CSU) Development Candidate Targeted for Q4 2024 Operat...